文献速递主动脉外科

开窗支架胸主动脉腔内修复远端弓部动脉瘤的结局

Outcomes of thoracic endovascular aortic repair using fenestrated stent grafts in patients with thoracic aortic distal arch aneurysms.
PubMed 文献 · Eur J Cardiothorac Surg · 2024-01-01

单中心回顾性研究纳入2007年4月至2016年12月连续101例远端主动脉弓动脉瘤患者,均行开窗支架胸主动脉腔内修复。30天死亡率为零,脑梗死4例、入路问题3例、脊髓损伤2例;观察期内免于动脉瘤相关死亡率为98%。作者认为该术式简单、并发症少,结局似可接受。

要点

  • 101例远端弓部动脉瘤患者行开窗支架胸主动脉腔内修复,30天死亡率为零。
  • 脑梗死4例、入路问题3例、脊髓损伤2例。
  • 观察期内免于动脉瘤相关死亡率为98%。

核心结论

  • 开窗支架胸主动脉腔内修复是简单术式,并发症少;作者认为即使存在内漏和动脉瘤扩大,追加治疗可减少动脉瘤相关死亡;基于本研究,该术式结局似可接受。

研究设计与样本

  • 单中心回顾性研究,2007年4月至2016年12月连续101例远端主动脉弓动脉瘤患者行开窗支架胸主动脉腔内修复。

主要发现

  • 30天死亡率为零;脑梗死4例、入路问题3例、脊髓损伤2例。
  • 研究期间101例中38例观察到各类内漏;出院时38例中20例存在轻微1型内漏。
  • 1型内漏中2例消失、8例无显著变化,但10例动脉瘤随时间扩大。
  • 10例1型内漏伴动脉瘤扩大患者中8例接受追加治疗;观察期内免于动脉瘤相关死亡率为98%。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Thoracic endovascular aortic repair (TEVAR) for aortic arch aneurysms is challenging because of anatomical restrictions and the presence of cervical branches. Revascularization of the cervical branch is required when conventional commercial stent grafts are used. TEVAR using fenestrated stent grafts (FSG) often does not require additional procedures to revascularize cervical branches. This study aimed to evaluate the features and initial and midterm outcomes of TEVAR using fenestrated stent grafts. METHODS: From April 2007 to December 2016, 101 consecutive patients underwent TEVAR using fenestrated stent grafts for distal aortic arch aneurysms at a single centre. Technical success, complications, freedom from aneurysm-related death, secondary intervention and aneurysm progression were retrospectively investigated. RESULTS: All the patients underwent TEVAR using fenestrated stent grafts. The 30-day mortality rate was zero. Cerebral infarction, access route problems and spinal cord injury occurred in 4, 3 and 2 patients, respectively. Each type of endoleak was observed in 38 of the 101 patients during the course of the study; 20/38 patients had minor type 1 endoleaks at the time of discharge. The endoleak disappeared in 2 patients and showed no significant change in 8 patients; however, the aneurysm expanded over time in 10 patients. Additional treatment was performed in 8 of the 10 patients with type 1 endoleaks and dilatation of the aneurysm. The rate of freedom from aneurysm-related death during the observation period was 98%. CONCLUSIONS: TEVAR with FSG is a simple procedure, with few complications. Additional treatment has been observed to reduce aneurysm-related deaths, even in patients with endoleaks and enlarged aneurysms. Based on this study, the outcomes of endovascular repair of aortic arch aneurysms using a fenestrated stent graft seem acceptable.

来源:Eur J Cardiothorac Surg,查看原文。版权归原作者所有。

引用

  1. Okamoto T, Yokoi Y, Sato N, et al. Outcomes of thoracic endovascular aortic repair using fenestrated stent grafts in patients with thoracic aortic distal arch aneurysms. Eur J Cardiothorac Surg. 2024. PMID: 38439540. doi:10.1093/ejcts/ezae062

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。